TipRanks
Sprint Bioscience AB (DE:5JA1)
FRANKFURT:5JA1
Germany Market
5JA1
Sprint Bioscience AB
RESEARCH TOOLSreports

Sprint Bioscience AB (5JA1) Ratios

0 Followers

Sprint Bioscience AB Ratios

DE:5JA1's free cash flow for Q2 2026 was kr0.00. For the 2026 fiscal year, DE:5JA1's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.09 7.60 1.14 1.67 3.78
Quick Ratio
 7.09 7.60 1.14 1.67 3.78
Cash Ratio
 6.57 7.25 0.76 1.44 3.19
Solvency Ratio
 5.40 5.31 -0.53 <0.01 -6.45
Operating Cash Flow Ratio
 4.86 4.78 -0.71 0.66 -6.40
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 86.40Mkr 115.39Mkr 4.46Mkr 23.27Mkr 25.65M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.16 1.15 4.54 2.25 1.33
Debt Service Coverage Ratio
 16.97 15.85 -432.98 0.00 0.00
Interest Coverage Ratio
 16.74 15.68 -491.70 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.04 0.07 <0.01 0.00 0.00
Net Debt to EBITDA
 -1.18 -1.29 1.45 -126.10 0.49
Profitability Margins
Gross Profit Margin
78.03%58.22%56.83%82.77%-73384.34%
EBIT Margin
56.21%58.22%-27.78%-0.10%-73031.33%
EBITDA Margin
56.99%58.86%-26.38%0.78%-72286.75%
Operating Profit Margin
56.21%58.22%-29.96%-1.67%-73384.34%
Pretax Profit Margin
54.37%54.88%-27.84%-0.87%-72493.98%
Net Profit Margin
54.37%54.88%-27.84%-0.87%-72493.98%
Continuous Operations Profit Margin
54.37%54.88%-27.84%-0.87%-72493.98%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
96.73%94.25%92.93%51.83%98.79%
Return on Assets (ROA)
72.55%67.13%-43.46%-0.70%-160.79%
Return on Equity (ROE)
94.09%76.97%-197.12%-1.58%-213.46%
Return on Capital Employed (ROCE)
86.82%81.67%-212.12%-3.04%-216.08%
Return on Invested Capital (ROIC)
86.82%81.67%-212.12%-3.04%-216.08%
Return on Tangible Assets
72.55%67.13%-43.46%-0.70%-160.79%
Earnings Yield
25.16%67.39%-16.78%-0.37%-263.06%
Efficiency Ratios
Receivables Turnover
 18.97 27.12 5.39 62.95 0.02
Payables Turnover
 8.36 15.87 5.21 1.52 16.37
Inventory Turnover
 0.00 0.00 0.00 0.00 -60.99K
Fixed Asset Turnover
 38.37 44.73 13.92 11.53 0.04
Asset Turnover
 1.33 1.22 1.56 0.81 <0.01
Working Capital Turnover Ratio
 1.47 2.79 4.73 2.06 <0.01
Cash Conversion Cycle
 -24.45 -9.55 -2.33 -233.60 14.82K
Days of Sales Outstanding
 19.24 13.46 67.77 5.80 14.85K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 >-0.01
Days of Payables Outstanding
 43.68 23.01 70.10 239.40 22.29
Operating Cycle
 19.24 13.46 67.77 5.80 14.85K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.65 0.90 -0.33 0.33 -1.40
Free Cash Flow Per Share
 0.65 0.90 -0.35 0.29 -1.40
CapEx Per Share
 <0.01 <0.01 0.02 0.04 0.00
Free Cash Flow to Operating Cash Flow
 0.99 1.00 1.06 0.89 1.00
Dividend Paid and CapEx Coverage Ratio
 136.81 888.64 -18.01 9.32 0.00
Capital Expenditure Coverage Ratio
 136.81 888.64 -18.01 9.32 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.50 0.50 -0.36 0.45 -711.49
Free Cash Flow Yield
22.76%61.29%-22.63%17.10%-258.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.96 1.48 -6.00 -272.54 -0.38
Price-to-Sales (P/S) Ratio
 2.16 0.81 1.66 2.36 275.58
Price-to-Book (P/B) Ratio
 3.34 1.14 11.75 4.30 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
 4.39 1.63 -4.42 5.85 -0.39
Price-to-Operating Cash Flow Ratio
 4.36 1.63 -4.66 5.22 -0.39
Price-to-Earnings Growth (PEG) Ratio
 0.01 >-0.01 >-0.01 2.74 >-0.01
Price-to-Fair Value
 3.34 1.14 11.75 4.30 0.81
Enterprise Value Multiple
 2.62 0.10 -4.84 175.36 0.11
Enterprise Value
 207.46M 9.43M 83.86M 69.44M -6.62M
EV to EBITDA
 2.62 0.10 -4.84 175.36 0.11
EV to Sales
 1.49 0.06 1.28 1.38 -79.76
EV to Free Cash Flow
 3.03 0.11 -3.40 3.40 0.11
EV to Operating Cash Flow
 3.01 0.11 -3.59 3.04 0.11
Tangible Book Value Per Share
 0.85 1.29 0.13 0.40 0.67
Shareholders’ Equity Per Share
 0.85 1.29 0.13 0.40 0.67
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 1.32 1.81 0.94 0.72 <0.01
Net Income Per Share
 0.72 0.99 -0.26 >-0.01 -1.43
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.97 0.94 1.00 8.59 0.99
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.22 0.00 0.86 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.91 0.91 1.19 -52.22 0.98
Currency in SEK